Research ArticleHIV

Cytomegaloviral determinants of CD8+ T cell programming and RhCMV/SIV vaccine efficacy

See allHide authors and affiliations

Science Immunology  25 Mar 2021:
Vol. 6, Issue 57, eabg5413
DOI: 10.1126/sciimmunol.abg5413

Article Information

vol. 6 no. 57

PubMed: 
Published By: 
History: 
  • Received January 12, 2021
  • Accepted March 4, 2021
  • .

Author Information

  1. Daniel Malouli1,*,
  2. Scott G. Hansen1,*,
  3. Meaghan H. Hancock1,
  4. Colette M. Hughes1,
  5. Julia C. Ford1,
  6. Roxanne M. Gilbride1,
  7. Abigail B. Ventura1,
  8. David Morrow1,
  9. Kurt T. Randall1,
  10. Husam Taher1,
  11. Luke S. Uebelhoer1,
  12. Matthew R. McArdle1,
  13. Courtney R. Papen1,
  14. Renee Espinosa Trethewy1,
  15. Kelli Oswald2,
  16. Rebecca Shoemaker2,
  17. Brian Berkemeier2,
  18. William J. Bosche2,
  19. Michael Hull2,
  20. Justin M. Greene1,
  21. Michael K. Axthelm1,
  22. Jason Shao3,
  23. Paul T. Edlefsen3,
  24. Finn Grey4,
  25. Jay A. Nelson1,
  26. Jeffrey D. Lifson2,
  27. Daniel Streblow1,
  28. Jonah B. Sacha1,
  29. Klaus Früh1, and
  30. Louis J. Picker1,
  1. 1Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
  2. 2AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD 21702, USA.
  3. 3Population Sciences and Computational Biology Programs, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
  4. 4Division of Infection and Immunity, Roslin Institute, University of Edinburgh, Edinburgh, UK.
  1. Corresponding author. Email: pickerl{at}ohsu.edu (L.J.P.); fruehk{at}ohsu.edu (K.F.)
  • * These authors contributed equally to this work.

Altmetric

Article usage

Article usage: March 2021 to July 2021

AbstractFullPdf
Mar 20214680389130
Apr 2021133017486
May 20213249932
Jun 20214337227
Jul 20211545725

Stay Connected to Science Immunology